International
Pfizer’s oral covid drug approved in China
Kathmandu, February 12. China has given conditional approval for Pfizer’s oral covid drug, Paxlovid. It is approved for treatment of mild to moderate adult patients of covid, with high risk of devloping a severe disease. National Medical Products Administration (NMPA), China’s top medical regulator revealed in a statement that although the drug has been approved, more
No ads found for this position
Trending News
- This Week
- This Month
